Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site.
read more
Wednesday, April 03, 2019
Chr. Hansen Holding A/S and Lonza have signed an agreement to establish a 50/50 joint venture to develop the live biotherapeutic products (LBPs) industry.
read more
Wednesday, January 19, 2022
Forbion, BioGeneration Ventures and Lonza announced the extension of their collaboration to include the development and manufacturing of small molecules.
read more
Bristol Myers Squibb and LOTTE Corporation announced that LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New York.
read more
Lyophilization Services of New England has acquired PSC Biotech’s cGMP aseptic fill finish manufacturing facility located in Madison, Wisconsin
read more
LSNE announced a strategic plan to expand its QC laboratory in Bedford and provide new employment opportunities for its analytical and operations workforce.
read more
LSNE has received GMP certification from Brazil's National Health Surveillance Agency - ANVISA following an inspection and audit of its manufacturing facility in Manchester, NH in February.
read more
Lyophilization Services of New England (LSNE) announced the acquisition of a sterile injectables manufacturing facility located in León, Spain.
read more
Tuesday, October 12, 2021
LSNE Contract Manufacturing, a leading global contract development and manufacturing organization (CDMO), today announces it has doubled its sterile drug product lyophilization capacity at its Madison, Wisconsin parenteral manufacturing facility, ...
read more
Wednesday, October 02, 2019
LSNE announces approval of an ANDA from the FDA, for a sterile injectable product manufactured at their aseptic fill finish facility in León, Spain.
read more
Tuesday, January 21, 2020
LSNE announced a successful Pre-Approval Inspection performed by the FDA at its aseptic fill finish facility in León, Spain.
read more
LSNE has announced the AEMPS has approved the manufacturing of clinical stage biotechnology based therapeutic products at its aseptic fill finish facility in León, Spain.
read more
Monday, September 19, 2022
LSPediA Inc., a cloud solutions provider for the pharmaceutical industry, added Patrick O'Donohue to its Leadership Team as Vice President of Operations.
read more
Friday, November 14, 2014
The Lubrizol Corporation announces an alliance between Lubrizol LifeSciences, a leading supplier of advanced materials for the healthcare industry, and
Particle Sciences, an integrated provider of drug development services.
read more
Lumanity announced the acquisition of Endpoint Outcomes, a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life.
read more